FTC Wants More Details On $5.2B Watson, Actavis Merger – site.law360.com
Law360, New York (July 12, 2012, 11:53 AM ET) -- Watson Pharmaceuticals Inc. said Thursday that the Federal Trade Commission has asked for further information about its €4.25 billion ($5.2 billion) plan to buy Swiss drugmaker Actavis Group as the agency ...
Subscribe to LegalLaw247.Com Newsletter